Unusual carbohydrate structure in the cell walls of tuberculosis bacteria-a new point of attack for drugs?July 27, 2004Even though we have lost much of our fear of tuberculosis in the industrialized countries, according to the WHO about 2 mio. people worldwide die each year of this infectious disease. Researchers at the University of Leeds have now discovered a carbohydrate with an unusual structure in the cell walls of Mycobacterium tuberculosis, the bacterium that causes tuberculosis. This could be a new starting point for pharmaceutical research. The main component of the cell walls of mycobacteria is a lipoarabinomannan (LAM), a molecule consisting of a branched segment made of many sugar building blocks, which is anchored to the cell wall by a fat-like segment. The sugars involved are almost exclusively arabinose and mannose. LAM plays an important role in infection, because it helps the mycobacteria to invade macrophages, dampen the immune response, and protect the invader from oxidation. Researchers working with Achim Treumann have recently discovered that some of the mannose end groups on the outside of the molecule carry another type of sugar building block, a so called methylthiopentofuranose. This type of sugar consists of five carbon atoms (pento) and one of its usual five oxygen atoms is replaced by a sulfur atom (thio), which is also attached to a methyl group (-CH3). This discovery is astonishing because this is the first time that a methylthiosugar has been identified as a component of a polysaccharide. The sulfur atom may be responsible for the protection from oxidation provided by LAM. However, this sugar is astonishing for another reason: it has an unexpected configuration. Like many sugars, it contains a five-membered ring made of four carbon atoms and one oxygen atom (furanose). There are eight different possibilities for the exact configuration of such a five-membered ring, because each of the four carbon atoms is attached to a further group of atoms, which could lie above or below the surface of the ring. Treumann and his co-workers took on the task of synthesizing all of the eight variations. NMR spectroscopic comparison of the eight sugars with the "original" natural form then allowed the team to identify the correct structure. In this case it has the "xylo" configuration. This is unusual, since sugars with the xylo configuration are usually only found in plants, not in bacteria. "The discovery of this new sugar component in LAM could help in the investigation of its role in mycobacterial infections," says Treumann. "As the sugar is very unusual, enzymes that are necessary for its biosynthesis could be a good point of attack for new tuberculosis medications." | |||||||||||||||||||||
|
Related Tuberculosis Current Events and Tuberculosis News Articles May hepatic granulomas be part of the histological spectrum of chronic hepatitis C? While older large series of patients with hepatic granulomas have found sarcoidosis and tuberculosis to be the most common causes of hepatic granulomas, recent works have noted some patients with chronic hepatic C and hepatic granulomas and no other obvious associations. Blocking the spread of antibiotic resistance in bacteria It's as simple as A, T, G, C. Northwestern University scientists have exploited the Watson-Crick base pairing of DNA to provide a defensive tool that could be used to fight the spread of antibiotic resistance in bacteria -- one of the world's most pressing public health problems. Researchers identify new leprosy bacterium A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. First trachea transplant without immunosuppression After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis. Proteomics Study Yields Clues As To How Tuberculosis Might Be Thwarting The Immune System A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. XDR-TB: Deadlier and more mysterious than ever New research has found that XDR-TB is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis (XDR-TB) is a growing public health threat that is only just beginning to be understood by medical and public health officials. Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. Parasites that live inside cells use loophole to thwart immune system St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide. Persistent bacterial infection exploits killing machinery of immune cells A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections. More Tuberculosis Current Events and Tuberculosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||